Showing results (1131-1140 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|September 17, 2021
Identification, Synthesis, and Characterization of a Major Circulating Human Metabolite of TRPV4 Antagonist GSK2798745Joseph E Pero, John J McAtee, David J Behm, et al.
ACS Medicinal Chemistry Letters|September 17, 2021
A Potent Fluorescent Reversible-Covalent Inhibitor of Cardiac Muscle ContractionFangze Cai, Thomas Kampourakis, Brittney A Klein, et al.
ACS Medicinal Chemistry Letters|September 16, 2021
Development of Pyrazolopyrimidine Anti-Wolbachia Agents for the Treatment of FilariasisPaul McGillan, Neil G Berry, Gemma L Nixon, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo ActivityJohn E Campbell, Kevin W Kuntz, Sarah K Knutson, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 DiabetesShrenik K Shah, Shuwen He, Liangqin Guo, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid TumorsAshvinikumar V Gavai, Claude Quesnelle, Derek Norris, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Synthesis and Pharmacology of α/β(3)-Peptides Based on the Melanocortin Agonist Ac-His-dPhe-Arg-Trp-NH2 SequenceAnamika Singh, Srinivasa R Tala, Viktor Flores, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Synthesis of mixed opioid affinity cyclic endomorphin-2 analogues with fluorinated phenylalaninesJustyna Piekielna, Renata Perlikowska, Jean Claude do-Rego, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Design, Synthesis, and Pharmacological Evaluation of Fused β-Homophenylalanine Derivatives as Potent DPP-4 InhibitorsTao Jiang, Yuren Zhou, Zhuxi Chen, et al.
ACS Medicinal Chemistry Letters|May 6, 2015
Discovery of benzimidazole oxazolidinediones as novel and selective nonsteroidal mineralocorticoid receptor antagonistsChristine Yang, Jaume Balsells, Hong D Chu, et al.
Pageof 438